id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0573-0018,FDA,FDA-2009-D-0573,International Conference on Harmonisation; Addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; Availability,Notice,Notice of Availability,2012-05-18T04:00:00Z,2012,5,2012-05-18T04:00:00Z,,2019-10-23T14:20:14Z,2012-12039,0,0,0900006481013f01
FDA-2009-D-0573-0019,FDA,FDA-2009-D-0573,International Conference on Harmonisation Addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology Derived Pharmaceuticals,Other,Guidance,2012-05-18T04:00:00Z,2012,5,2012-05-18T04:00:00Z,,2024-11-07T22:28:28Z,,1,0,09000064810134f5